European insurance giant Axa reported mixed first-half results for 2025, with net profit declining 2% to €3.9 billion due to unfavorable currency effects. However, on an adjusted basis, earnings rose 6% to €4.5 billion, surpassing analyst expectations. Revenue grew 7% to €64.3 billion, driven by strong performance across all segments, particularly property-casualty and life-health insurance. The company maintained a robust solvency ratio of 220%, underscoring its financial stability.
Strategic Moves to Boost Growth
Axa announced the €500 million acquisition of Italian direct insurer Prima, doubling its auto insurance footprint in Italy. The deal aligns with its growth ambitions in lucrative markets. Concurrently, Axa launched a €3.8 billion share buyback program to offset dilution from the recent sale of its asset management arm. CEO Thomas Buberl reaffirmed mid-term targets, including 6-8% annual earnings-per-share growth, signaling confidence despite currency headwinds.
Ad
Axa Stock: Buy or Sell?! New Axa Analysis from February 7 delivers the answer:
The latest Axa figures speak for themselves: Urgent action needed for Axa investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from February 7.
Axa: Buy or sell? Read more here...
